Rockville, US, 2022-Nov-07 — /EPR Network/ — This market research report on Psychotic Disorder Treatment presents growth drivers, restraints, opportunities, and segmentation based on applications, [read full press release…]
New York, United States, 2022-May-18 — /EPR Network/ — Environmental sciences are being used for creating awareness regarding hygiene and robust health. With adoption of [read full press release…]
New York, United States, 2022-May-13 — /EPR Network/ — With the established fact that AI technology would be helping the medical professionals in execution of [read full press release…]
Fact.MR recently added a report on the global Psychotic Disorder Treatment market that aims to decode the leading forces of demand and supply. The report [read full press release…]
LAKELAND, FL, 2021-Sep-22 — /EPR Network/ — Even after a patient receives a diagnosis of schizophrenia and is prescribed an antipsychotic medication, they may still experience negative symptoms of schizophrenia, like [read full press release…]
Albany, US, 2018-Jun-22 — /EPR Network/ —Medical institutions and pharmaceutical companies are akin on developing niche products that accelerate schizophrenia therapeutics pertaining to cognitive symptoms. [read full press release…]
Albany, US, 2018-Apr-14 — /EPR Network/ — Market Research HUB has added a Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H1 2018, [read full press release…]
Albany, US, 2017-Jul-26 — /EPR Network/ — Cognitive impairment associated with schizophrenia (CIAS) show various symptoms which have a very negative impact on the patients’ quality [read full press release…]
